Clinical Trials Sponsored by REVA Medical, Inc

Total 3239 results

Cephalon, Inc.

Terminated

Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Traumatic Brain Injury

United States
NuPathe Inc.

Completed

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine (NP101-007)

Migraine Disorders

United States
NuPathe Inc.

Completed

Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®

Healthy

United States
NuPathe Inc.

Completed

Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period (NP101-011)

Migraine Disorders

United States
Cephalon, Inc.

Completed

Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer

Breast Cancer

Austria, Belgium, France, Germany, Italy, Spain
Cephalon, Inc.

Terminated

A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, Belgium, Czechia, France, Germany, Hungary, Poland, Portugal, Spain, Ukraine, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.
NCGS, Inc.

Completed

A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine

Episodic Migraine Headache

United States
NuPathe Inc.

Completed

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

Compare Bioequivalence Patches Previously Used in the NP101-007 Study

United States
NuPathe Inc.

Completed

Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine

Acute Migraine
NuPathe Inc.

Completed

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months (NP101-009)

Migraine Disorders

United States
Teva Branded Pharmaceutical Products R&D, Inc.
Eisai Inc.

Completed

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

Dementia | Alzheimer's Disease

United States, Canada, Australia, South Africa
Teva Pharma GmbH
Anfomed GmbH

Completed

Azilect® In Wearing-Off (AIWO) (AIWO)

Parkinson's Disease

Germany
Kennedy Medical Group
Teva Pharmaceuticals USA

Terminated

Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine

Chronic Migraine

United States
University Medical Center Groningen
Teva Pharma

Completed

Effects of QVAR in Smokers With Asthma (OLiVIA)

Asthma

Netherlands
MetroHealth Medical Center
Teva Pharmaceuticals USA

Completed

Screening Tools for Obstructive Sleep Apnea (OSA) in Hospitalized Medical Patients (STOMP)

Obstructive Sleep Apnea

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

Migraine

United States, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age

Migraine

United States, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age

Migraine

United States, Canada, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel (NEUGR-002)

Chemotherapy-induced Neutropenia
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma (ELIOT)

Asthma

United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Active, not recruiting

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine

Migraine

China
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®

Asthma

Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease (MermaiHD)

Huntington's Disease

Austria, Belgium, France, Germany, Italy, Portugal, Spain, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment

Non-Hodgkin Lymphoma

China
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties (Bravura)

Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia

Fibromyalgia

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Asthma

United States, Bulgaria, Czechia, Germany, Poland
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)

Post-Traumatic Headache

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis

Lupus Arthritis

United States, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

Lupus Nephritis

United States, Canada, France, Russian Federation, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone® (CONFIDENCE)

Multiple Sclerosis

United States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids

Asthma

United States, Puerto Rico
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis | Hay Fever

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Non-invasive Measures of Distal Lung Disease in Asthmatics

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children

Asthma

United States, Puerto Rico
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

Episodic Cluster Headache

United States, Australia, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Withdrawn

A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome

Interstitial Cystitis
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation (DEAR)

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy

Female Contraception | Contraception

United States, Israel
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee

Osteoarthritis of the Knee

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

Chronic Obstructive Pulmonary Disease

United States, Australia, New Zealand
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

Persistent Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Withdrawn

A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes (NASH)

Type 2 Diabetes Mellitus | Nonalcoholic Steatohepatitis
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

Migraine

United States, Canada, Czechia, Finland, Israel, Japan, Poland, Russian Federation, Spain
Teva Branded Pharmaceutical Products R&D, Inc.

Withdrawn

A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) (LIBRETTO)

Relapsing Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

Asthma

United States, Croatia, Mexico, Poland, Ukraine
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)

Chronic Myeloid Leukemia

United States, Belgium, France, Korea, Republic of

3

Subscribe